Summary.-The transfer of tumour-specific cytotoxicity against a murine fibrosarcoma has been demonstrated in vitro using xenogeneic RNA extracted from tumourcell-immune animals. Poly(A)-tailed messenger RNA from immunogenic RNA was isolated by passage through an oligo(dT)-cellulose column, and evaluated to determine whether the same tumour-specific cytotoxicity could be transferred. Aliquots of normal C3H mouse lymphocytes were treated with poly(A)-containing immune RNA, whole-cell immune RNA lacking poly(A) and total cellular immune RNA.
RIBONUCLEIC ACID (RNA) extracted from sensitized lymphoid cells has been shown to transfer immunological responsiveness. This immunogenic RNA (IRNA) free of detectable antigen has been shown to induce humoral antibody production (Bell and Dray, 1973; Cohen and Parks, 1964; Mitsuhashi et at., 1968; Pinchuck et al., 1968) and to induce cellular immunity (Likhite and Sehon, 1972; Paque and Dray, 1972; Thor and Dray, 1973) . The mediation of anti-tumour cytotoxicity in vitro has been demonstrated using both syngeneic Schlager et al., 1975) and xenogeneic IRNA (Alexander et al., 1967; Brower et al., 1975; Dodd et al., 1973 ; Pilch et al., 1974) . In most cases the technique used to assess cell-mediated transfer with IRNA was in the form of a microcytotoxicity test in which tumour target-cell destruction was noted. Less used assays were designed to detect migration-inhibition factor (Schlager et al., 1975; Thor and Dray, 1973 ) and lymphoblastogenesis (Deckers et al., 1975; Dodd et al., 1973) . The in vivo models for mediation of specific tumour cytotoxicity produced results demonstrating temporary tumour regression (Alexander et al., 1967; Schlager et al., 1975) , decreased rate (Londner et al., 1968) , or inhibition of tumour growth (Ramming and Pilch, 1970; Skinner et at., 1976) and protection against tumours with prolonged survival (Kennedy et al., 1969; Rigby, 1969) .
The intracellular location of IRNA from sensitized lymphocytes was found to be in the nucleus-free cytoplasmic fractions (deKernion et al., 1974) . The immunologically active components of total cellular IRNA were found to have sedimentation values of 10-1 68 (Billello et al., 1976; Dodd et al., 1973; Kern et al., 1976) and to contain sequences of polyadenylic acid (Paque and Nealon, 1977) . Wlhile it is apparent that IRNA is capable of transferring a variety of immune responses, the active component of IRNA seems to be confined to a narrow range of sedimentation coefficients. Since IRNA has been shown to function in both the humoral and cellular responses, perhaps they are operating, at least in the initial stages, by similar mechanisms. These studies were undertaken to define further the role of this fraction of IRNA in initiating an immune response. Poly(A)-containing messenger RNA (mRNA) was isolated by the use of oligo-(dT)-cellulose chromatography from total cellular syngeneic IRNA. Most eucaryotic mRNAs contain a poly(A) segment at their 3'-hydroxyl end (Adesnik et al., 1972; Lee et al., 1971 ) and thus bind to oligo(dT)-cellulose at the appropriate ionic strength (Mach et al., 1973) . Increased levels of cytotoxicity were found in the poly(A)-containing fraction of IRNA. The transfer of tumour cytotoxicity with poly(A)-containing IRNA (poly(A)+IRNA) would support the theory that IRNA operates as informational RNA.
It has not been clear whether the cytotoxicity observed in similar studies has been due to direct lymphocyte-tumour cell interaction (e.g. T-cell killing). This study investigates the ability of this poly(A)+ IRNA to transfer specific cytotoxicity to nylon-wool-purified populations of lymphocytes. The non-adherent cells were the active recipients of the poly(A)+IRNA component, while from these studies the adherent cells appeared to play no role in the transfer of specific cytotoxicity.
MIATERIALS AND METHODS
Animials. The animals used were inbred C3H/HeJ mice 6-12 w%Aeeks old (Jackson Laboratories, Bar Harbor, Maine).
Cell lines.-The tumour system used was a polyoma-virus-induced fibrosarcoma of C3H mouse origin termed 4198. A variant, 4198V, cloned from 4198, lhas been shown to contain about 9 times more tumour-specific antigen than 4198 on its cell surface. The more tumorigenic 4198 was used to produce tumours, whereas 4198V was used to immunize mice (Ting et al., 1972) . The 4198V cell also served as a target cell in assays detecting tumourspecific immune activity. The LM cell, cloned from L cells (Kuchler and Merchant, 1956 ) was used as a control cell. LM is a nontumorigenic cell of C3H mouse origin. Another tumour cell line, S91, was used as a control of specificity. S91 is a malignant melanoma transplant that arose spontaneously in a DBA female mouse and has been shown to be tumorigenic in C3H/HeJ mice (Cloudman, 1941) . Cell culturing.-All cell lines were maintained in vitro at 37°C and 50% CO2 as monolayer cultures in RPMI-1640 plus 10% heatinactivated foetal calf serum (FCS) (Grand Island, N.Y.) .
Immunization of mice.-Mice (C3H/HeJ) were given 3 i.p. injections of 4 x 106 4198V tumour cells every 5-6 days. Five days after the last injection, mice were challenged with 5 X 105 of 4198 tumour cells. Non-immune mice will produce palpable tumours in 10-14 days after i.m. injection of 5 x 105 4198V cells. Mice resisting tumour challenge were considered immune, and their spleens were removed and frozen in dry-ice/acetone. The control cell lines LM and S91 were used to immunize C3H mice in the same manner as the 4198V, with the exception of the nontumorigenic LM cell, for which mice were given 5 x 106 cells per injection.
RAVA extraction.-RNA was extracted from frozen normal and immune C3H/HeJ mouse spleens according to the methods described in a previous paper (Dodd et al., 1973) .
Isolation of poly(A)-tailed mRNA.-Total cellular RNA at a concentration of 20-50 A260 u/ml (A standard 1 mg/ml solution absorbs 24 units at 260 nm) in O.i1M Tris-HCl (pH 7 4) and 0-5M NaCl was applied to an oligo(dT)-cellulose column (Collaborated Research, Waltham, Mass.) with a bed volume of 2 ml (0 4 g powder). The column was previously equilibrated with the same buffer. The column was washed twice with twice the bed volume (4 ml) to remove unbound material. The RNA that failed to bind to the column was passed through, collected and termed poly(A)-lacking RNA (poly(A)-RNA). Poly-(A)+RNA was eluted with 2 ml of diethylpyrocarbonate (Sigma, St. Louis, Mo.) treated triple-distilled H20. Both fiactions were precipitated by adjusting the salt concentration to 0dIM with lOX TNE (O.1M Tris, IM NaCl, 001M EDTA, pH 8 3) and by the addition of 2 volumes of absolute ethanol at -20°C overnight. The preparations were centrifuged for 30 min at 12,000 g in a Sorvall Model RC2-B centrifuge at -20°C. The resulting RNA pellets were dissolved in Ca+2-and Mg+2-free phosphate-buffered saline and frozen at -70°C. The oligo(dT)-cellulose was regenerated by washing with 0-M NaOH and reequilibrated with 0-O1M Tris-HCl (pH 7 4) containing 0-5M NaCl. Chromatography on oligo(dT)-cellulose was performed at room temperature.
Sucrose density-gradient evaluation. Sucrose gradients of 5-20% sucrose (Sigma, St.
Louis, Mo.) were formed by an ISCO Model 180 gradient former. Fifty to 100 ,tg of IRNA were layered on the surface of the gradient, followed by centrifugation in a Beckman Model L-2 ultracentrifuge at 193,000 g in an SW 41 swinging bucket rotor for 5 h at 4°C. Using an ISCO Model 180 density-gradient fractionator, the sucrose gradient was fractionated and absorbance (A) read at 254 nm through the flow cell of an ISCO Model 222 spectrophotometer.
The preceding preparative methods were performed on RNA from normal C3H/HeJ mice (NRNA) and from immunized C3H/HeJ mice.
RNA treatment of lymphocytes. Lymphocytes were obtained from the spleens of normal C3H/HeJ mice. The spleens were teased and cells separated on a Hypaque-Ficoll gradient (Boyum, 1968) . The medium used was RPMI 1640 containing 10% heat-inactivated FCS, 20 jug gentamicin/ml (Schering, Kenil- w%rorth, N.J.) buffered with HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid, Grand Island Biologicals, Grand Island, N.Y.) at pH 7-4. The lymphocytes were adjusted to a concentration of 2 x 106/ml and were consistently 97-100% viable as determined by trypan-blue exclusion. Lymphocytes at a concentration of 4 x 106/2 ml w,,ere treated in plastic test tubes (Falcon Plastics, Cherry Hill, N.J.) with 50 ,ug of DEAE-dextran and a determined amount of RNA (50 jug, 100 ,ug, etc.) . The lymphocytes were incubated with the RNA and DEAE-dextran for 30 min at 37°C and 500 CO2. After incubation the cells were washed twice with medium described above and adjusted to a cell concentration of 106/ml for use in the microcytotoxicity assay.
Microcytotoxicity assay.-The assay is an adaptation of the Takasugi microcytotoxicity assay (Takasugi and Klein, 1970 Separation of T and B lymiphocytes on nylonantd glass-wool column,ns. Populations of lymphocytes were separated by glass and nylon wool as previously described (Gravely and Kreier, 1976) . The numbers of 0+ cells Nere determined by incubation of lymphocytes, anti-0 serum, and complement (Filippi et al., 1976) . The percent 0+ cells was calculated using lymphocytes treated with normal rabbit serum as control. B cells will form rosettes with sensitized complement-coated sheep erythrocytes termed EAC (Bianco et al., 1970) . The percent rosettes was calculated on the basis of counting 100 cells after incubation of equal volumes of 106/ml lymphocytes Awith 100 EAC. Analyses of whole-cell RNA and of the RNA fractions on sucrose gradients are shown in Fig. 1 . The profile obtained with whole-cell RNA (A) had 3 peaks: the lowmol-wt (4-6S) RNA which contains transfer RNA, the second peak at about 12-20S which comprises mRNA and smaller ribosomal RNA, and the larger-mol-wt (20-35S) RNA which accounts for larger ribosomal RNA. The profile obtained with poly(A)-RNA (B) closely resembles that found with total cellular RNA. Since poly(A)+RNA makes up such a small amount in comparison to total cell RNA (4-6%), no significant difference should be seen in sucrose-gradient profiles. The sedimentation profile of poly(A)+RNA (C) appeared as one broad peak ranging from 9 to 20S. The broadness of the peak suggests that some contamination with highermol-wt ribosomal RNA could be present in the preparation. The profiles obtained with these 3 RNA preparations agree with similar reports using oligo(dt)-cellulose for isolation of poly(A)-tailed mRNA (Green et al., 1976) . Unless the sucrose-gradient profiles resembled those shown here, RNA was not used for experimentation. mained constant throughout the assay. These results agree with previous work done in our laboratory (Dodd et al., 1973) and others (Kern et al., 1976; Singh et al., 1977) .
Poly(A)-tailed mRNA was isolated from total cellular IRNA using oligo(dt)-cellulose chromatography, and normal lymphocytes were treated with doses of poly(A)+IRNA ranging from ] 65 Mg to 32 5 Mug. As shown in Fig. 2 The effect of varying the effector: targetcell ratio from 1: 1 to 400: 1 is seen in Fig.  3 . The optimum dose of poly(A)+IRNA and poly(A)-IRNA was used as determined previously. Maximum activity was observed using a 200: 1 effector: target-cell ratio. Increasing the number of lymphocytes beyond this ratio did not increase tumour-specific cytotoxicity.
Evaluation of glass-and nylon-wool columns Splenic lymphocytes were separated on a Hypaque-Ficoll gradient and passed through glass wool to remove macrophages and then through nylon wool to separate and enrich for B-and T-cell populations. For unknown reasons, B lymphocytes stick preferentially to nylon wool (Eisen et al., 1 cI'729 Paqom-of hilman nerinheral-ohond Fi(c. 4 lymphocytes through long nylon-wool columns at 370C was shown to result in a 2-3-fold depletion of complement-receptor lymphocytes (CRL) (Epstein et al., 1971) . As shown in Fig. 4 , glass-and nylon-wool columns were found to be effective for enriching for CRLs and 0+ lymphocytes. An average of 550 of the total cell population was recovered after passage through glass wool, and 700% of the glass-wool yield was recovered after passage through nylon wool.
The population eluted from nylon wool was 500o CRLs and 5% 0+ cells. The nonadherent population was 86% 6+ cells and 300 CRLs. Even though some cells could not be identified either by a complement receptor or by the 0 antigen, the nylonwool technique did enrich for the two populations. These percentages agree with those reported previously (Gravely and Kreier, 1976 ).
c,I
L clF-`' I' Cytotoxicity with adherent and non-adherent populations of cells Treatments with the various RNA components were performed using nylon-wool purified adherent and non-adherent populations of cells in place of unseparated lymphocytes. These were substituted and used in the microcytotoxicity assav. As shown in Table II , no significant levels of cytotoxicity were found, using adherent cells, with any of the IRNA components. In looking at the non-adherent cell population, high levels of cytotoxicity (5900) (Kern et al., 1976 ). An RNA fraction which accelerated skin allograft rejection in rabbits sedimented in sucrose in the 8-18S region (Mannick and Egdahl, 1964) . Similarly, an active RNA extracted from human lymphnodes capable of transferring PPD reactivity to unsensitized cells appeared localized in the 8-12S fraction (Thor and Dray, 1973) . As demonstrated in Table I , RNA extracted from the lymphoid tissue of mice immune to 4198V fibrosarcoma cells transferred specific cytotoxicity for the 4198V target cell and not for the LM or the S91 cell lines. Likewise, RNA from both S91-and LM-immune animal transferred a specific response for each respective target cell. Also, immune lymphocytes isolated from the spleens of each group of mice did not cross-react with target cells of a different origin. The transfer of specific cytotoxicity by syngeneic and xenogeneic IRNA has been shown using other tumour cell line systems (Kern et al., , 1977 .
The optimum dosage of poly(A)+IRNA was determined (Fig. 2) The studies performed with adherent and non-adherent cell populations suggested that not only was poly(A)+IRNA the active component of whole-cell IRNA, but also that the tumour-specific cytotoxicity may be due to T-cell-mediated cytotoxicity. Since enrichment of the treated lymphocyte population for T cells did not increase the level of cytotoxicity over that seen with unseparated cell populations, it appears that the maximum level of cytotoxicity for the system has been attained. Cytotoxicity levels of 35-450 observed with turnour-immune lymphocytes in the same assay system substantiate this.
At this point, one can only speculate as to what happens to the RNA once it is taken into the cell. This messeng,er could enter the cell, attach to the ribosomes, and then begin to translate protein. This protein could change an appropriate cellsurface receptor that commits the cell to a cellular cytotoxic response. The protein could be the light chain of an antibody molecule or a regulatory protein. It is also possible that poly(A)-tailed mRNA could be a template for reverse transcriptase, in which case a DNA copy of this message would be integrated into the cell's genome. At the present time, very little is known about gene regulation in a normal cell, much less what goes on in an immune cell or in a cell given the information from an immune cell.
The active fraction of IRNA responsible for transfer of tumour-specific cytotoxicity has been isolated and further characterized. However, IRNA fractions which mediate other types of immune reactions (e.g. blocking antibody and antibodydependent cell-mediated cytotoxicity) may be present, and further studies on this matter are in progress in this laboratory.
